Innovative Therapies

Globally, diabetes affects over 463 million adults, with type 2 diabetes accounting for about 90% of cases. New therapies like SGLT2 inhibitors and GLP-1 receptor agonists have shown promise in managing blood glucose and weight. For example, SGLT2 inhibitors have been associated with a 30% reduction in hospitalization for heart failure. Continued research into beta-cell regeneration and immunotherapy could offer hope for future breakthroughs.

    Related Conference of Innovative Therapies

    October 21-22, 2024

    28th World Congress on Nutrition and Food Sciences

    Paris, France
    November 18-19, 2024

    6th World Summit on Health Nutrition

    London, UK
    November 28-29, 2024

    Food Safety Meet 2024

    Bali, Indonesia
    November 28-29, 2024

    7th World Congress on Food and Nutrition

    Bali, Indonesia
    February 20-21, 2025

    8th International Conference on Food Safety and Health

    Amsterdam, Netherlands
    February 24-25, 2025

    31st International Conference on Clinical Nutrition

    London, UK
    June 24-25, 2025

    24th International Congress on Nutrition and Health

    Amsterdam, Netherlands

    Innovative Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in